The Cost of Stopping (Futility) Rules Telaprevir and Boceprevir in the Treatment of Genotype 1 Hepatitis C Patients in Brazil

被引：0
|
作者：
Morais, A. D. [1 ]
Pereira, M. L. [1 ]
机构：
[1] Janssen Cilag Farmaceut, Sao Paulo, Brazil
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.137
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A345 / A345
页数：1
相关论文
共 50 条
  • [41] Boceprevir targets chronic hepatitis C genotype 1
    不详
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2011, 72 (09) : 489 - 489
  • [42] Dermatological adverse effects during genotype-1 hepatitis C treatment with the protease inhibitors telaprevir and boceprevir. Patient management
    Picard, Odile
    Cacoub, Patrice
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2012, 36 (05) : 437 - 440
  • [43] ADDING BOCEPREVIR YIELDS BETTER COST-SAVING FOR CHRONIC HEPATITIS C GENOTYPE 1 TREATMENT IN THAILAND
    Ferrante, S.
    Elbasha, E. H.
    Piratvisuth, T.
    Tanwandee, T.
    Lerdlitruangsin, S.
    Thongsawat, S.
    VALUE IN HEALTH, 2014, 17 (07) : A677 - A677
  • [44] Boceprevir and telaprevir for the treatment of chronic hepatitis C: safety management in clinical practice
    Hezode, Christophe
    LIVER INTERNATIONAL, 2012, 32 : 32 - 38
  • [45] Cost-effectiveness analysis of boceprevir for the treatment of chronic hepatitis C virus genotype 1 infection in Portugal
    Elbasha E.H.
    Chhatwal J.
    Ferrante S.A.
    El Khoury A.C.
    Laires P.A.
    Applied Health Economics and Health Policy, 2013, 11 (1) : 65 - 78
  • [46] BOCEPREVIR OR TELAPREVIR IN COMBINATION WITH PEGINTERFERON FOR HEPATITIS C GENOTYPE 1 INFECTION: AN INDIRECT COMPARISON META-REGRESSION ANALYSIS
    Cooper, C.
    Druyts, E.
    Thorlund, K.
    Mills, E.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S451 - S451
  • [47] Low SVR Rates in Clinical Practice for Treating Genotype 1 Chronic Hepatitis C with Protease Inhibitors Boceprevir and Telaprevir
    Perry H. Dubin
    Seth N. Sclair
    Rene Rico
    Amelia K. Boehme
    Emerson Y. Chen
    Paul Martin
    William M. Lee
    Digestive Diseases and Sciences, 2015, 60 : 272 - 274
  • [48] Use of boceprevir and telaprevir in patients with hepatitis C virus infection (practical considerations)
    Crespo, Gonzalo
    Lens, Sabela
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2012, 35 (05): : 337 - 343
  • [49] Cost-Effectiveness Modeling Study of boceprevir for the treatment of patients with genotype 1 chronic hepatitis C virus infection in Hong Kong
    Ferrante, Shannon A.
    Yuen, Man-Fung
    Wong, Vincent W.
    Loo, Ching-Kong
    Chhatwal, Jagpreet
    Elbasha, Elamin
    HEPATOLOGY, 2013, 58 : 1136A - 1136A
  • [50] Multicenter Experience Using Telaprevir or Boceprevir With Peginterferon and Ribavirin to Treat Hepatitis C Genotype 1 After Liver Transplantation
    Pungpapong, Surakit
    Aqel, Bashar A.
    Koning, Ludi
    Murphy, Jennifer L.
    Henry, Tanisha M.
    Ryland, Kristen L.
    Yataco, Maria L.
    Satyanarayana, Raj
    Rosser, Barry G.
    Vargas, Hugo E.
    Charlton, Michael R.
    Keaveny, Andrew P.
    LIVER TRANSPLANTATION, 2013, 19 (07) : 690 - 700
12345